Psychiatry and Neurology, Neurology · Saint Clairsville, OH
NPI
1518917152
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
109 Plaza Dr
Saint Clairsville, OH, 43950
Phone (740) 526-0731
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
1,218 services
Medicare patients, 2024
531
Average age 71
Drug cost, 2024
$852K
5,426 prescriptions
Company payments, 2025
$698
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gurmeet Singh was code 99214 (office e&m - established), 404 times for 258 patients. In total Gurmeet Singh billed 1,218 services in 40 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 404 | 258 | $83.56 | $34K |
| 99213 Office E&M - Established | Office | 378 | 279 | $57.86 | $22K |
| 99204 Office E&M - New | Office | 63 | 63 | $105.29 | $6,633 |
| 95886 Electrical Nerve Conductivity | Office | 59 | 42 | $63.01 | $3,718 |
| 99215 Office E&M - Established | Office | 36 | 32 | $124.58 | $4,485 |
| 95816 Neurologic | Office | 31 | 31 | $281.82 | $8,736 |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 30 | 29 | $24.18 | $725 |
| 93971 Duplex Scan - Extremity Veins | Facility | 30 | 29 | $13.66 | $410 |
| 95909 Electrical Nerve Conductivity | Office | 16 | 16 | $76.90 | $1,230 |
| 99205 Office E&M - New | Office | 13 | 13 | $140.57 | $1,827 |
| 95819 Neurologic | Office | 13 | 13 | $318.41 | $4,139 |
| 95911 Electrical Nerve Conductivity | Office | 11 | 11 | $155.22 | $1,707 |
| 93925 Duplex Scan - Extremity Arteries | Facility | 11 | 11 | $28.21 | $310 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 11 | 11 | $25.90 | $285 |
By year: 2022 $114K for 1,328 services; 2023 $108K for 1,305 services; 2024 $96K for 1,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gurmeet Singh prescribed most often to Medicare patients was Gabapentin, with 430 prescriptions and refills. In total Gurmeet Singh wrote 5,426 Medicare prescriptions that cost $852K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 430 | 857 | 106 | $9,270 |
| Donepezil Hcl Generic | 385 | 811 | 118 | $3,913 |
| Levetiracetam Generic | 318 | 635 | 65 | $13K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 282 | 625 | 67 | $8,695 |
| Primidone Generic | 219 | 389 | 55 | $4,932 |
| Topiramate Generic | 194 | 396 | 50 | $1,842 |
| Memantine Hcl Generic | 193 | 405 | 48 | $5,081 |
| Propranolol Hcl Generic | 189 | 427 | 59 | $3,465 |
| Ropinirole Hcl Generic | 168 | 368 | 42 | $2,803 |
| Lacosamide Generic | 161 | 209 | 30 | $39K |
| Pregabalin Generic | 137 | 288 | 48 | $6,196 |
| Quetiapine Fumarate Generic | 129 | 187 | 31 | $1,616 |
| Duloxetine Hcl Generic | 124 | 267 | 26 | $1,958 |
| Escitalopram Oxalate Generic | 111 | 240 | 37 | $888 |
| Lamotrigine Generic | 104 | 225 | 18 | $2,179 |
Brand drugs: 467 claims; generic drugs: 4,915 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gurmeet Singh $698 ($698 in general payments such as food, travel and fees) from 11 companies. The largest payer was Neurocrine BioSciences, Inc. with $176.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 8 | $176 |
| Amgen Inc. AMGN | 1 | $112 |
| Abbvie Inc. ABBV | 6 | $110 |
| Pfizer Inc. PFE | 5 | $95.83 |
| SK Life Science, Inc. | 2 | $40.85 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $39.5 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $32.71 |
| AGEPHA Pharma FZ LLC | 2 | $30.16 |
| Axsome Therapeutics, Inc. AXSM | 1 | $26.41 |
| C2N Diagnostics, LLC | 1 | $19.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.